Добірка наукової літератури з теми "Prostate cancer; epigenetic modification"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Prostate cancer; epigenetic modification".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Prostate cancer; epigenetic modification"
Albany, Costantine, Ajjai S. Alva, Ana M. Aparicio, Rakesh Singal, Sarvari Yellapragada, Guru Sonpavde, and Noah M. Hahn. "Epigenetics in Prostate Cancer." Prostate Cancer 2011 (2011): 1–12. http://dx.doi.org/10.1155/2011/580318.
Повний текст джерелаDonkena, Krishna Vanaja, Charles Y. F. Young, and Donald J. Tindall. "Oxidative Stress and DNA Methylation in Prostate Cancer." Obstetrics and Gynecology International 2010 (2010): 1–14. http://dx.doi.org/10.1155/2010/302051.
Повний текст джерелаZheng, Jianghua, Jinglong Wang, Xueqing Sun, Mingang Hao, Tao Ding, Dan Xiong, Xiumin Wang, et al. "HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification." Clinical Cancer Research 19, no. 6 (January 22, 2013): 1400–1410. http://dx.doi.org/10.1158/1078-0432.ccr-12-2888.
Повний текст джерелаNgollo, Marjolaine, Aslihan Dagdemir, Seher Karsli-Ceppioglu, Gaelle Judes, Amaury Pajon, Frederique Penault-Llorca, Jean-Paul Boiteux, Yves-Jean Bignon, Laurent Guy, and Dominique J. Bernard-Gallon. "Epigenetic modifications in prostate cancer." Epigenomics 6, no. 4 (August 2014): 415–26. http://dx.doi.org/10.2217/epi.14.34.
Повний текст джерелаIppolito, Luigi, Giuseppina Comito, Matteo Parri, Marta Iozzo, Assia Duatti, Francesca Virgilio, Nicla Lorito, et al. "Lactate Rewires Lipid Metabolism and Sustains a Metabolic–Epigenetic Axis in Prostate Cancer." Cancer Research 82, no. 7 (February 8, 2022): 1267–82. http://dx.doi.org/10.1158/0008-5472.can-21-0914.
Повний текст джерелаKgatle, Mankgopo M., Asgar A. Kalla, Muhammed M. Islam, Mike Sathekge, and Razia Moorad. "Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy." Prostate Cancer 2016 (2016): 1–11. http://dx.doi.org/10.1155/2016/5653862.
Повний текст джерелаOrea, María J., Javier C. Angulo, Ana González-Corpas, David Echegaray, Marcos Marvá, María V. T. Lobo, Begoña Colás, and Santiago Ropero. "Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer." International Journal of Molecular Sciences 24, no. 1 (January 2, 2023): 803. http://dx.doi.org/10.3390/ijms24010803.
Повний текст джерелаLópez, Judith, Ana M. Añazco-Guenkova, Óscar Monteagudo-García, and Sandra Blanco. "Epigenetic and Epitranscriptomic Control in Prostate Cancer." Genes 13, no. 2 (February 18, 2022): 378. http://dx.doi.org/10.3390/genes13020378.
Повний текст джерелаBartkowiak-Wieczorek, Joanna, Radosław Kujawski, Anna Bogacz, and Marcin Ożarowski. "An introduction to genetic and epigenetic changes in prostate gland – implications in efficacy of phytotherapy of benign prostatic hyperplasia and prostate cancer." Journal of Medical Science 84, no. 2 (June 30, 2015): 97–103. http://dx.doi.org/10.20883/medical.e23.
Повний текст джерелаCimadamore, Alessia, Silvia Gasparrini, Marina Scarpelli, Andrea Doria, Roberta Mazzucchelli, Francesco Massari, Liang Cheng, Antonio Lopez-Beltran, and Rodolfo Montironi. "Epigenetic Modifications and Modulators in Prostate Cancer." Critical Reviews™ in Oncogenesis 22, no. 5-6 (2017): 439–50. http://dx.doi.org/10.1615/critrevoncog.2017020964.
Повний текст джерелаДисертації з теми "Prostate cancer; epigenetic modification"
Mohamed, M. "Epigenetic biomarkers in prostate cancer." Thesis, Queen's University Belfast, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426926.
Повний текст джерелаZhang, Qunshu. "Epigenetic Regulation of Apoptosis in Prostate Cancer." Diss., North Dakota State University, 2015. https://hdl.handle.net/10365/27614.
Повний текст джерелаChinaranagari, Swathi. "Epigenetic Silencing of ID4 in Prostate Cancer: Mechanistic Insight." DigitalCommons@Robert W. Woodruff Library, Atlanta University Center, 2015. http://digitalcommons.auctr.edu/cauetds/13.
Повний текст джерелаTaurozzi, Alberto. "Genetic and epigenetic profiling of human prostate cancer cell subsets." Thesis, University of York, 2016. http://etheses.whiterose.ac.uk/17511/.
Повний текст джерелаRibarska, Teodora [Verfasser]. "Expression and epigenetic regulation of imprinted genes in prostate cancer / Teodora Ribarska." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2013. http://d-nb.info/1036727513/34.
Повний текст джерелаKadio, Bernard. "A Calcium-Centered Socio-Ecological Model of Prostate Cancer Disparities: Preliminary Studies and Findings." Thesis, Université d'Ottawa / University of Ottawa, 2020. http://hdl.handle.net/10393/40685.
Повний текст джерелаGupta, Yukti Hari. "An investigation into BORIS expression in prostate cancer cells and its role in epigenetic regulation of the androgen receptor gene." Thesis, University of Essex, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.635911.
Повний текст джерелаWu, Mengchu. "The Epigenetic Silencing of PMP24 During the Progression of Prostate Cancer from an Androgen-Dependent to Androgen-Independent State in the LNCAP Cell Model: a Dissertation." eScholarship@UMMS, 2005. https://escholarship.umassmed.edu/gsbs_diss/209.
Повний текст джерелаSiouda, Maha. "Transcriptional regulation and epigenetic repression of the tumor suppressor DOK1 in viral- and non viral-related carcinogenesis." Thesis, Lyon 1, 2013. http://www.theses.fr/2013LYO10163.
Повний текст джерелаThe newly identified tumor suppressor DOK1 (downstream of tyrosine kinases1) inhibits cell proliferation, negatively regulates MAP kinase activity, opposes leukemogenesis, and promotes cell spreading, motility, and apoptosis. DOK1 also plays a role in the regulation of immune cell activation, including B cells. The tumor suppressor role of DOK1 was demonstrated in animal models. DOK1 knockout mice show a high susceptibility to develop leukemia, hematological malignancies as well as lung adenocarcinomas and aggressive histiocytic sarcoma. In addition, we previously reported that the DOK1 gene can be mutated and its expression is down-regulated in human malignancies such as Burkitt’s lymphoma cell lines (BL) and chronic lymphocytic leukemia (CLL). However, very little is known about the mechanisms underlying DOK1 gene regulation and silencing in viral- and non viral-related tumorigenesis. In the present project, we first characterized the DOK1 promoter. We have shown the role of E2F1 transcription factor as the major regulator of DOK1 expression and how DOK1 plays a role in DNA stress response though opposing cell proliferation and promoting apoptosis. We demonstrated that DOK1 gene expression is repressed in a variety of human cancers, including head and neck, Burkitt’s lymphoma and lung cancers, as a result of aberrant hypermethylation. We investigated the link between the epigenetic events and DOK1 silencing in non viral head and neck cancer cell lines, and by Epstein Barr virus in relation to its oncogenic activity in human B cells and neoplasia such as Burkitt’s lymphoma. These data provide novel insights into the regulation of DOK1 in viral and non viral-related carcinogenesis, and could define it as a potential cancer biomarker and an attractive target for epigeneticbased therapy
Perriaud, Laury. "Étude systémique des cibles génomiques de la methyl-CpG binding domain protein 2 (MBD2), un répresseur transcriptionnel dépendant de la méthylation de l'ADN : évolution de la distribution de MBD2 dans un modèle syngénique de progression tumorale mammaire." Phd thesis, Université Claude Bernard - Lyon I, 2010. http://tel.archives-ouvertes.fr/tel-00833153.
Повний текст джерелаКниги з теми "Prostate cancer; epigenetic modification"
Dean, Michael, and Karobi Moitra. Biology of Neoplasia. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0002.
Повний текст джерелаЧастини книг з теми "Prostate cancer; epigenetic modification"
Nelson, William G., Michael C. Haffner, Angelo M. De Marzo, and Srinivasan Yegnasubramanian. "Epigenetic Changes in Prostate Cancer." In Prostate Cancer: A Comprehensive Perspective, 169–79. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2864-9_14.
Повний текст джерелаValdés-Mora, Fátima, and Clare Stirzaker. "Epigenetic Alterations in Primary Prostate Cancer." In Molecular Pathology Library, 193–211. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-64096-9_13.
Повний текст джерелаChiam, Karen, Tanya Kate Day, and Tina Bianco-Miotto. "Recent Updates on Epigenetic Biomarkers for Prostate Cancer." In Epigenetics and Cancer, 129–50. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6612-9_8.
Повний текст джерелаNatesan, Ramakrishnan, Shweta Aras, Samuel Sander Effron, and Irfan A. Asangani. "Epigenetic Regulation of Chromatin in Prostate Cancer." In Advances in Experimental Medicine and Biology, 379–407. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-32656-2_17.
Повний текст джерелаKumar, Sanjay, James A. Stokes, Udai P. Singh, Kumar S. Bishnupuri, and Manoj K. Mishra. "Enhancer of Zeste Homology 2 (Ezh2), an Epigenetic Regulator: A Possibility for Prostate Cancer Treatment." In Epigenetic Advancements in Cancer, 229–44. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-24951-3_10.
Повний текст джерелаCeletti, Angela. "Epigenetic Mechanisms: Histone Acetylation, DNA Methylation, miRNA, Chromatin Modifiers." In Prostate Cancer: Shifting from Morphology to Biology, 201–10. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-7149-9_12.
Повний текст джерелаVeltri, Robert W., and Christhunesa S. Christudass. "Nuclear Morphometry, Epigenetic Changes, and Clinical Relevance in Prostate Cancer." In Cancer Biology and the Nuclear Envelope, 77–99. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4899-8032-8_4.
Повний текст джерелаSavio, Andrea J., and Bharati Bapat. "Beyond the Island: Epigenetic Biomarkers of Colorectal and Prostate Cancer." In Methods in Molecular Biology, 103–24. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1804-1_6.
Повний текст джерелаTakayama, Ken-ichi, and Satoshi Inoue. "Investigation of Androgen Receptor Signaling Pathways with Epigenetic Machinery in Prostate Cancer." In Molecular Oncology: Underlying Mechanisms and Translational Advancements, 205–22. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-53082-6_10.
Повний текст джерелаPeriyasamy, Loganayaki, Abhaya Krishnan, Mekhala Kumaravel Palanichami, Ilangovan Ramachandran, R. Ileng Kumaran, Jonathan Behlen, Jone Stanley, and Sridhar Muthusami. "Reactive Oxygen Species: Induced Epigenetic Modification in the Expression Pattern of Oncogenic Proteins." In Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 1–16. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-1247-3_68-1.
Повний текст джерелаТези доповідей конференцій з теми "Prostate cancer; epigenetic modification"
Singhal, Udit, Anirban Sahu, John R. Prensner, Qi Cao, and Arul M. Chinnaiyan. "Abstract 2869: SChLAP1 mediated epigenetic modifications in prostate cancer." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2869.
Повний текст джерелаShankar, Eswar, Omair Iqbal, Natarajan Bhaskaran, Gauri Deb, Gregory T. MacLennan, Pingfu Fu, and Sanjay Gupta. "Abstract 5084: Epigenetic modifications involving reactivation of RECK inhibiting MMP-9 and MMP-2 in prostate cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-5084.
Повний текст джерелаShankar, Eswar, Omair Iqbal, Natarajan Bhaskaran, Gauri Deb, Gregory T. MacLennan, Pingfu Fu, and Sanjay Gupta. "Abstract 5084: Epigenetic modifications involving reactivation of RECK inhibiting MMP-9 and MMP-2 in prostate cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-5084.
Повний текст джерелаSpiliopoulou, Pavlina, Josephine Walton, Suzanne Dowson, Alex Binks, Oliver Maddocks, Peter Adams, and Iain McNeish. "Abstract A37: Epigenetic modification of ovarian cancer immunogenicity." In Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.ovca17-a37.
Повний текст джерелаLin, Hui-Yi, Anders Berglund, Thomas Sellers, Ardeshir Hakam, Hyun Park, Julio Pow-Sang, and Jong Y. Park. "Abstract 291: Genomewide scale epigenetic profile and prostate cancer recurrence." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-291.
Повний текст джерелаPuca, Loredana, Dong Gao, Myriam Kossai, Joanna Cyrta, Clarisse Marotz, Juan Miguel Mosquera, Theresa Y. MacDonald, et al. "Abstract B41: Targeting androgen-independent prostate cancer through epigenetic reprogramming." In Abstracts: AACR Special Conference: Chromatin and Epigenetics in Cancer; September 24-27, 2015; Atlanta, GA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.chromepi15-b41.
Повний текст джерелаKumar, Devi Sharanya Sampath, and Alan Wells. "Abstract 4016: Epigenetic regulation of CXCR3 splicing in prostate cancer cells." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4016.
Повний текст джерелаMaitland, Norman James, and John Packer. "Abstract B23: Epigenetic control of prostate epithelial stem cell differentiation." In Abstracts: AACR Special Conference on Developmental Biology and Cancer; November 30 - December 3, 2015; Boston, Massachusetts. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3125.devbiolca15-b23.
Повний текст джерелаBattaglia, Sebastiano, Steven Seedhouse, Ellen Karasik, Dominic Smiraglia, and Barbara Foster. "Abstract 3390: Epigenetic corruption of the Vitamin D signaling in prostate cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3390.
Повний текст джерелаNelson, William, Michael Haffner, Traci Speed, Byron Lee, and Srinivasan Yegnasubramanian. "Abstract CN01-01: Genetic and epigenetic changes in prostate cancer as targets for prevention." In Abstracts: Frontiers in Cancer Prevention Research 2008. American Association for Cancer Research, 2008. http://dx.doi.org/10.1158/1940-6207.prev-08-cn01-01.
Повний текст джерелаЗвіти організацій з теми "Prostate cancer; epigenetic modification"
Margueron, Raphael F. An Epigenetic Link to Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, November 2006. http://dx.doi.org/10.21236/ada484222.
Повний текст джерелаShurin, Michael R. Epigenetic Regulation of Chemokine Expression in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, December 2006. http://dx.doi.org/10.21236/ada460756.
Повний текст джерелаTlsty, Thea D. Modification of Epigenetic Changes in Cancer by the Stromal Environment. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada430193.
Повний текст джерелаBattaglia, Sebastiano. Targeting LSD1 Epigenetic Signature in Castration-Recurrent Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada612062.
Повний текст джерелаPark, Jong Y. Genetic and Epigenetic Biomarkers for Recurrent Prostate Cancer After Radiotherapy. Fort Belvoir, VA: Defense Technical Information Center, May 2014. http://dx.doi.org/10.21236/ada609389.
Повний текст джерелаCase, Adam J., and Frederick E. Domann. Epigenetic Control of Prolyl and Asparaginyl Hydroxylases in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2010. http://dx.doi.org/10.21236/ada542700.
Повний текст джерелаCase, Adam J. Epigenetic Control of Prolyl and Asparaginyl Hydroxylases in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2009. http://dx.doi.org/10.21236/ada511993.
Повний текст джерелаFranceschi, Renny T. Epigenetic Control of Prostate Cancer Metastasis: Role of Runx2 Phosphorylation. Fort Belvoir, VA: Defense Technical Information Center, April 2013. http://dx.doi.org/10.21236/ada580104.
Повний текст джерелаPark, Jong. Genetic and Epigenetic Biomarkers for Recurrent Prostate Cancer After Radiotherapy. Fort Belvoir, VA: Defense Technical Information Center, May 2013. http://dx.doi.org/10.21236/ada581491.
Повний текст джерелаCase, Adam. Epigenetic Control of Prolyl and Asparaginyl Hydroxylases in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2011. http://dx.doi.org/10.21236/ada552430.
Повний текст джерела